Literature DB >> 211266

Structure of the joint region and the termini of the DNA of herpes simplex virus type 1.

M J Wagner, W C Summers.   

Abstract

Analysis of restriction endonuclease cleavage sites within the inverted, repeated sequences in the joint region of the DNA of herpes simplex virus type 1 strain KOS revealed the presence of two types of sequence heterogeneity. The first was an insertion of 280 base pairs or multiples of 280 base pairs which was found in approximately half of all DNA molecules from every plaque-purified stock of virus. These insertions seemed to be tandem duplications of sequences which were present at the joint and correspond closely to the inverted terminal redunancy. The second type of heterogeneity was due to variable insertions and deletions which were present in some, but not all, plaque-purified virus stocks. Comparison of restriction fragments from the joint region with fragments from the termini indicated that in the simplest observed molecules of herpes simplex virus type 1 DNA, only one copy of the inverted terminal redundancy was present at the joint. A map of restriction endonuclease cleavage sites in the joint region is presented.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 211266      PMCID: PMC354176     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Structure and function of herpesvirus genomes. II. EcoRl, Sbal, and HindIII endonuclease cleavage sites on herpes simplex virus.

Authors:  J Skare; W C Summers
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

2.  Analysis of herpesvirus DNA substructure by means of restriction endonucleases.

Authors:  J B Clements; R Cortini; N M Wilkie
Journal:  J Gen Virol       Date:  1976-02       Impact factor: 3.891

3.  Sequence arrangement in herpes simplex virus type 1 DNA: identification of terminal fragments in restriction endonuclease digests and evidence for inversions in redundant and unique sequences.

Authors:  N M Wilkie; R Cortini
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

4.  Nucleotide sequence of bacteriophage phi X174 DNA.

Authors:  F Sanger; G M Air; B G Barrell; N L Brown; A R Coulson; C A Fiddes; C A Hutchison; P M Slocombe; M Smith
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

5.  Translocatable elements in procaryotes.

Authors:  N Kleckner
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

6.  Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose--ethidium bromide electrophoresis.

Authors:  P A Sharp; B Sugden; J Sambrook
Journal:  Biochemistry       Date:  1973-07-31       Impact factor: 3.162

7.  Herpes simplex virus DNA.

Authors:  Y Becker; H Dym; I Sarov
Journal:  Virology       Date:  1968-10       Impact factor: 3.616

8.  A simple method for DNA restriction site mapping.

Authors:  H O Smith; M L Birnstiel
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

9.  Size, composition, and structure of the deoxyribonucleic acid of herpes simplex virus subtypes 1 and 2.

Authors:  E D Kieff; S L Bachenheimer; B Roizman
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

10.  Physical maps for Herpes simplex virus type 1 DNA for restriction endonucleases Hind III, Hpa-1, and X. bad.

Authors:  N M Wilkie
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

View more
  70 in total

1.  Molecular analysis of chromosome-mediated gene transfer.

Authors:  G A Scangos; K M Huttner; S Silverstein; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

2.  Anatomy of herpes simplex virus DNA. XII. Accumulation of head-to-tail concatemers in nuclei of infected cells and their role in the generation of the four isomeric arrangements of viral DNA.

Authors:  R J Jacob; L S Morse; B Roizman
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

3.  Recombination of the internal direct repeat element DR2 responsible for the fluidity of the a sequence of herpes simplex virus type 1.

Authors:  K Umene
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  Relationship of herpes simplex virus genome configuration to productive and persistent infections.

Authors:  Sara A Jackson; Neal A DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-09       Impact factor: 11.205

5.  Analysis of herpes simplex virus type 1 DNA packaging signal mutations in the context of the viral genome.

Authors:  Lily Tong; Nigel D Stow
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

6.  Identification of the herpes simplex virus DNA sequences present in six herpes simplex virus thymidine kinase-transformed mouse cell lines.

Authors:  J M Leiden; N Frenkel; F Rapp
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

7.  Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.

Authors:  Shih-Hsin Chiu; Meng-Chuan Wu; Chung-Chun Wu; Yu-Ching Chen; Su-Fang Lin; John T-A Hsu; Chung-Shi Yang; Ching-Hwa Tsai; Kenzo Takada; Mei-Ru Chen; Jen-Yang Chen
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation.

Authors:  G C Perng; R L Thompson; N M Sawtell; W E Taylor; S M Slanina; H Ghiasi; R Kaiwar; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Herpes simplex virus type 1 restriction fragment polymorphism determined using southern hybridization.

Authors:  K Umene; T Eto; R Mori; Y Takagi; L W Enquist
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

10.  Fragments from both termini of the herpes simplex virus type 1 genome contain signals required for the encapsidation of viral DNA.

Authors:  N D Stow; E C McMonagle; A J Davison
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.